These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33921905)

  • 1. Engineering of Saposin C Protein Chimeras for Enhanced Cytotoxicity and Optimized Liposome Binding Capability.
    Sandin SI; Gravano DM; Randolph CJ; Sharma M; de Alba E
    Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33921905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Studies on the Interaction between Saposin-like Proteins and Synthetic Lipid Membranes.
    Sandin SI; de Alba E
    Methods Protoc; 2022 Feb; 5(1):. PubMed ID: 35200535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SapC-DOPS nanovesicles as targeted therapy for lung cancer.
    Zhao S; Chu Z; Blanco VM; Nie Y; Hou Y; Qi X
    Mol Cancer Ther; 2015 Feb; 14(2):491-8. PubMed ID: 25670331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SapC-DOPS nanovesicles induce Smac- and Bax-dependent apoptosis through mitochondrial activation in neuroblastomas.
    Sulaiman MK; Chu Z; Blanco VM; Vallabhapurapu SD; Franco RS; Qi X
    Mol Cancer; 2015 Apr; 14():78. PubMed ID: 25889084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SapC-DOPS as a Novel Therapeutic and Diagnostic Agent for Glioblastoma Therapy and Detection: Alternative to Old Drugs and Agents.
    Kaynak A; Davis HW; Vallabhapurapu SD; Pak KY; Gray BD; Qi X
    Pharmaceuticals (Basel); 2021 Nov; 14(11):. PubMed ID: 34832975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting and cytotoxicity of SapC-DOPS nanovesicles in pancreatic cancer.
    Chu Z; Abu-Baker S; Palascak MB; Ahmad SA; Franco RS; Qi X
    PLoS One; 2013; 8(10):e75507. PubMed ID: 24124494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of elevated cell surface phosphatidylserine with saposin C-dioleoylphosphatidylserine nanodrug as individual or combination therapy for pancreatic cancer.
    Davis HW; Kaynak A; Vallabhapurapu SD; Qi X
    World J Gastrointest Oncol; 2021 Jun; 13(6):550-559. PubMed ID: 34163572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotherapy of Brain Tumors with Phosphatidylserine-Targeted Radioiodinated SapC-DOPS Nanovesicles.
    Davis HW; Vallabhapurapu SD; Chu Z; Wyder MA; Greis KD; Fannin V; Sun Y; Desai PB; Pak KY; Gray BD; Qi X
    Cells; 2020 Aug; 9(9):. PubMed ID: 32854321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of cancer cells using SapC-DOPS nanovesicles.
    Davis HW; Hussain N; Qi X
    Mol Cancer; 2016 May; 15(1):33. PubMed ID: 27160923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular imaging of membrane interfaces reveals mode of beta-glucosidase activation by saposin C.
    Alattia JR; Shaw JE; Yip CM; Privé GG
    Proc Natl Acad Sci U S A; 2007 Oct; 104(44):17394-9. PubMed ID: 17954913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic cancer: current standards, working towards a new therapeutic approach.
    Olowokure O; Qi X
    Expert Rev Anticancer Ther; 2014 May; 14(5):495-7. PubMed ID: 24621210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusogenic domain and lysines in saposin C.
    Qi X; Chu Z
    Arch Biochem Biophys; 2004 Apr; 424(2):210-8. PubMed ID: 15047193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity and Selectivity in Skin Cancer by SapC-DOPS Nanovesicles.
    Abu-Baker S; Chu Z; Stevens AM; Li J; Qi X
    J Cancer Ther; 2012 Aug; 3(4):321-326. PubMed ID: 25485166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusion behaviour of aquaporin Z incorporated proteoliposomes investigated by quartz crystal microbalance with dissipation (QCM-D).
    Li X; Wang R; Wicaksana F; Zhao Y; Tang C; Torres J; Fane AG
    Colloids Surf B Biointerfaces; 2013 Nov; 111():446-52. PubMed ID: 23850749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution structure of human saposin C: pH-dependent interaction with phospholipid vesicles.
    de Alba E; Weiler S; Tjandra N
    Biochemistry; 2003 Dec; 42(50):14729-40. PubMed ID: 14674747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear magnetic resonance study of protein-protein interactions involving apoptosis regulator Diva (Boo) and the BH3 domain of proapoptotic Bcl-2 members.
    Santiveri CM; Sborgi L; de Alba E
    J Mol Recognit; 2012 Dec; 25(12):665-73. PubMed ID: 23192964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposome-chaperoned cell-free synthesis for the design of proteoliposomes: Implications for therapeutic delivery.
    Lu M; Zhao X; Xing H; Xun Z; Yang T; Cai C; Wang D; Ding P
    Acta Biomater; 2018 Aug; 76():1-20. PubMed ID: 29625253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-selective targeting and cytotoxicity by liposomal-coupled lysosomal saposin C protein.
    Qi X; Chu Z; Mahller YY; Stringer KF; Witte DP; Cripe TP
    Clin Cancer Res; 2009 Sep; 15(18):5840-51. PubMed ID: 19737950
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.